commentr/StutterJune 22, 2022

Content

Dr. Gerald Maguire and his team at Emalex Bio is in Phase 2 approval right now with Ecopipam, and the FDA has fast track assured. Neuralink will probably take another 10-15 years. And there is no other drug in the pipeline. Maybe China will surprise us with something at some point. Kind regards from the stuttering CEO

Themes

Community & SupportMeds & Substances

Subthemes

Research & ResourcesHelpful Med Outcomes

Codes (1)

dopamine_modulators_vmat2_inhibitors